Request for Applications
Editor-in-Chief, Clinical Pharmacology in Drug Development
The American College of Clinical Pharmacology® (ACCP) seeks qualified applicants for the position of Editor-in-Chief of the Clinical Pharmacology in Drug Development (CPDD). The due date for applications is September 20, 2024.
The CPDD is one of the two official publications of the ACCP and is an international, peer-reviewed journal focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in healthy subjects during the early phases of drug development, or after marketing approval. Acceptance of a manuscript in CPDD is determined by scientific rigor and technical soundness rather than perceived importance of the presented results. In addition to publication of original research articles, CPDD encourages submission (with or without invitation) of Editorials, Commentaries and Reviews.
Since its introduction in 2012, CPDD has included an international Editorial Board consisting of basic and clinical scientists who are well-established in the field of clinical pharmacology and represent academic, regulatory and industry sectors. The Editorial Board works closely with the Editor-in-Chief to provide strategic oversight and guidance, as well as to assist with operational requirements.
The CPDD is published by Wiley Periodicals Inc, a subsidiary of John Wiley & Sons Inc (Publisher).
Roles and Responsibilities
The Editor-in-Chief is responsible for the selection and management of all editorial content for the CPDD. Together with the ACCP Publications Committee, the Editor-in-Chief will implement the strategic vision for the CPDD. While working with the Publisher, Editorial Board and Editorial Support Team, the Editor-in-Chief will seek to assure objective and timely review of all manuscripts submitted for publication by reviewers with demonstrated expertise in the subject addressed in each manuscript and make the final selection for publication in the CPDD in an efficient and timely manner. The Editor-in-Chief is also responsible for promoting the CPDD to individual, academic, industry and government audiences, with the goal of continually enhancing the reputation of the CPDD and assuring that the vision for the CPDD is consistent with the Mission & Vision, as well as the strategic goals of the ACCP. Finally, the Editor-in-Chief shall work to assure the scientific integrity of the CPDD and seek to enhance the reputation of the CPDD in the scientific and clinical communities. The Editor-in-Chief is expected to attend the ACCP Annual Meeting.
This position shall be for a term of five years.
Compensation
A quarterly stipend will be provided to the Editor-in-Chief for the provision of services. The stipend will be commensurate with the experience of the Editor-in-Chief and the anticipated annual (cumulative) workload for the CPDD. Reimbursement will be provided for travel expenses involved in attending ACCP's Annual Meeting in accordance with ACCP approved reimbursement policies.
Application Process
Applicants should submit the following materials to the ACCP Executive Office at [email protected] by September 20, 2024.
1. A brief cover letter including your motivation for applying for this role
2. An up-to-date, detailed curriculum vitae
3. Up to 3 of your published papers that you consider to be the most relevant to this role
4. A description of your prior editorial experience and relevant skills
5. A plan to develop and grow the CPDD (addressing the global move towards open access specifically), detailing specific ideas for your future work as Editor-in-Chief (maximum 2 pages) as it applies to ACCP’s Mission & Vision
6. Additional information to support the application
The application should be submitted by email on or before September 20, 2024 to:
Krista L. Levy
Executive Director
American College of Clinical Pharmacology®
[email protected]
571-293-3493
Direct questions to:
Navin Goyal, PhD, FCP
Chair, Search Committee for the CPDD Editor-in-Chief
[email protected]